A recent study by Darlington et al. (82) showed that the measurement of the proportion of T-cell receptor (TCR) CD4+ Va2.3+ T-cells in BALF could also be a biomarker in addition to the CD4/CD8 ratio, to support a sarcoidosis diagnosis. Here, CD8A is linked to sarcoidosis.